Monday, September 26, 2011

2012 CPT Code Changes for Clinical Lab Codes

CPT 2012 brings new codes for HIV Antigen and NMPP22 – check them out.

On January 1 next year, 2011 CPT codes will be replaced by new codes. So if your lab runs a single-result test for HIV-1 antigens and HIV-1/HIV-2 antibodies, you will have a new code to report the service next year. This is one of the two new CPT codes that made an entry at the annual CMS laboratory public meeting for pricing new test codes for payment on the clinical laboratory fee schedule.

Even though there are no new codes on the horizon, this year's meeting featured much discussion about drug test coding.

Two new clinical lab test codes in CPT 2012

This time, CPT 2012 codes will bring these two clinical lab test codes: 863XX, 873XX. Both these codes will provide more specific reporting for newer tests you may have added to your menu recently.

Drug Testing Leads ‘Reconsideration'

Apart from pricing recommendations for the new codes, Centers for Medicare & Medicaid (CMS) heard public comments for reconsideration requests for these 2011 CPT codes : G0434, G0435, 83861, 86481 and 87906.

Drug screen

Many commentators suggested changing G0434 to cover only CLIA waived tests, while coding up with a new code for moderate complexity tests priced at four times G0434. The present grouping under G0434 comes down hard on clinical labs that carry out these tests while using instrumented moderate complexity systems. The moderate complexity instruments come with some clinical advantages - say for instance higher specificity that commentators said shouldn't be discouraged by coding and reimbursement.

Pricing Proposal & Comment

The agency received industry input during the July 18, 2011, public meeting for the new codes. It'll post final payment determinations on the same Website in October 2011.

Even though payment method for codes can be either crosswalk or gap-fill, almost all presenters at the public meeting recommended crosswalks for the just-in codes.

No comments:

Post a Comment